Your browser doesn't support javascript.
loading
A modular cell-free protein biosensor platform using split T7 RNA polymerase.
McSweeney, Megan A; Patterson, Alexandra T; Loeffler, Kathryn; de Larrea, Regina Cuellar Lelo; McNerney, Monica P; Kane, Ravi S; Styczynski, Mark P.
Afiliação
  • McSweeney MA; School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332, United States.
  • Patterson AT; School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332, United States.
  • Loeffler K; School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332, United States.
  • de Larrea RCL; School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332, United States.
  • McNerney MP; School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332, United States.
  • Kane RS; School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332, United States.
  • Styczynski MP; School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332, United States.
bioRxiv ; 2024 Jul 19.
Article em En | MEDLINE | ID: mdl-39071415
ABSTRACT
Conventional laboratory protein detection techniques are not suitable for point-of-care (POC) use because they require expensive equipment and laborious protocols, and existing POC assays suffer from long development timescales. Here, we describe a modular cell-free biosensing platform for generalizable protein detection that we call TLISA (T7 RNA polymerase-Linked ImmunoSensing Assay), designed for extreme flexibility and equipment-free use. TLISA uses a split T7 RNA polymerase fused to affinity domains against a protein. The target antigen drives polymerase reassembly, inducing reporter expression. We characterize the platform, then demonstrate its modularity by using 16 affinity domains against four different antigens with minimal protocol optimization. We show TLISA is suitable for POC use by sensing human biomarkers in serum and saliva with a colorimetric readout within one hour and by demonstrating functionality after lyophilization. Altogether, this technology could have potentially revolutionary impacts, enabling truly rapid, reconfigurable, equipment-free detection of virtually any protein.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article